Crossmark

Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy

Crossref DOI link: https://doi.org/10.1016/j.gastre.2019.12.002

Published Print: 2020-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alcedo, Javier

Gracia, Marta

García-Cámara, Paula

Palacín, Carmen

Gallego, Sonia

Jimeno-Ayllon, Cristina

Frago, Santiago

Aured, Isabel

Luzón, Lara
Funding

Funding for this research was provided by:

Allergan Inc.
License Information

Text and Data Mining valid from 2020-06-01
More Information

This article is maintained by: Elsevier

Article Title: Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2019.12.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2019.12.002

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below